Q&A

Developing The Right Oral Dosage Form For Pediatric Medicines

Evonik3

When it comes to the development of drug products for use by pediatric populations, the selection of the right formulation is critical. The developmental status of the target patient population will not only strongly influence the dosage form and strength, but also other formulation factors including taste or odor masking and swallowability. Working with a CDMO that has decades of expertise in the development of pediatric dosage forms can be critical to ensuring regulatory and commercial success. In this interview with Ashish Guha, Associate Director of Oral Formulations at Evonik Health Care, we review some of the key factors that need to be considered during initial formulation development.

VIEW THE Q&A!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Pharmaceutical Online